BPG is committed to discovery and dissemination of knowledge
Basic Study
Copyright: ©Author(s) 2026.
World J Hepatol. Jun 27, 2026; 18(6): 120427
Published online Jun 27, 2026. doi: 10.4254/wjh.120427
Figure 6
Figure 6 Silencing ARNT2 inhibits UBE2Z expression, which is associated with hepatocellular carcinoma status and poor prognosis. A: Expression patterns of input genes in liver hepatocellular carcinoma (top 25) were analyzed using the ULCAN online tool; B: The correlation between ARNT2 and UBE2Z expression was analyzed using the ULCAN online tool; C: The association between ARNT2 expression and survival was analyzed using the ULCAN online tool; D-H: UBE2Z expression in liver hepatocellular carcinoma under different clinical conditions was assessed using the ULCAN online tool; I: UBE2Z levels were analyzed by Western blot; J: UBE2Z expression was evaluated using immunohistochemical staining. Results are presented as the mean ± SD, n = 3. bP < 0.01; cP < 0.001. LIHC: Liver hepatocellular carcinoma.


Write to the Help Desk